Fortrans ipsen powder cleaned the colon (4 packs)

Dosage form Foam
Specifications 4 package box
Ingredient Sodium bicarbonate, macrogol 4000, sodium chloride, sodium saccharin, sodium sulfate, potassium
Indication Constipation
Contraindication Gut

Ingredient

Composition information	Content
Sodium bicarbonate	1.68
Macrogol 4000	64
Sodium chloride	1.46
Sodium Saccharin	0.1
Sodium sulfate	5.7
Potassium	0.75

Uses

indications

Fortrans are indicated for the colon cleansing to prepare for patients before:

Endoscopy or colon X-ray. When drinking, they increase the amount of fluid in the intestines. This amount of fluid is not absorbed, so the solution has a laxative effect.

Dynamic pharmacokinetics

electrolytes contained in the mixed drug solution like in the small intestine/plasma, the electricity exchange is considered zero.

Pharmacokinetic data confirms that Macrogol 4000 is not absorbed, and does not biological changes in the gastrointestinal tract when used orally.

Before taking Fortrans ipsen powder cleaned the colon (4 packs)

How to use

oral medication.

Dosage

Each package must be mixed in 1 l water. Stir until the dough is completely dissolved. The dose of about 1 l of mixed solution for every 15 to 20 kg of body weight, corresponding to the average of 3–4 l the solution.

Can take medicine once or divide many times, ensuring that the total amount of mixed drug solution is always taken (average 3–4 l depending on the weight of the patient):

With a small dose: Can be taken 2 l in the evening before doing the procedure and 2 l in the morning to do the procedure, the last cup of medicine to take before the procedure from 3 to 4 hours, or take 3 l in the evening before and 1 l in the morning of the procedure, the last cup of medicine to take before the procedure from 3 to 4 hours. 2 L.

The doctor may adjust the oral rate depending on the clinical condition of the patient and the potential diseases attached.

Patients with renal failure: There is currently no enough data for this group of patients.

Children: Safety and effectiveness of Fortrans in children aged

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

No report on overdose use.

However, patients should be monitored with water -electricity balance disorders and the degree of dehydration in case of overdose attached to severe diarrhea.

What to do when you forget 1 dose?

No report.

Side Effects

When using Fortrans, you may experience unwanted effects (ADR).

Common, ADR> 1/100

Digestive: abdominal pain, abdominal tightness, vomiting.

Uncommon, 1/1000

No report.

Not determined frequency

Immune: sensitivity (anaphylaxis, angioedema, urticaria, rash, itching).

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindications:

Fortrans drugs are contraindicated in the following cases:

allergies to the active ingredient or any ingredient of the drug. chemical.

Be cautious when used

This drug is only used for older patients with weakness when monitoring of a doctor.

diarrhea due to Fortrans may be due to absorption disorders when taking stimulants.

This drug contains polyethyleneglycol.

Very rare allergic reactions (anaphylaxis, erythema, itching, edema) are reported with drugs containing polyethyleneglycol.

Electrolyte disorders are unwanted effects due to the isotonic composition of the drug. However, the exception of electrolyte water disorders has been reported in risky patients. Patients with electrolyte disorders should be adjusted before the colon cleansing.

This drug must be used carefully in patients with water -electrolytes or on patients who are using simultaneously, increasing the volume of solution and causing electrolytes (hypoglyc sodium and hypokalemia), or may increase the risk of potential complications (patients change kidney function, heart failure patients or are being treated with diuretics). In this case, patients need to be monitored appropriately.

This drug must be used carefully and only used when a doctor monitor in patients with bedridden or patients changing nerve function and/or movement disorders due to the risk of inhaled pneumonia. These patients must take medicine when sitting and the last measure is through the nose - thick.

There is a risk of higher pulmonary edema patients with heart failure and kidney failure due to water overload.

This drug contains 1.967 g of sodium in each package. Precautions when used in diseases with strict salt diet.

The ability to drive and operate machinery

There is no research on the effect of the drug on the ability to drive and/or operate machinery has been done.

Pregnancy

without or very little data from the use of Fortrans in pregnant women. Animal studies are incomplete for reproductive toxicity. Fortrans is only used if the benefits are greater than the risk.

The period of breastfeeding

without or very little data from the use of Fortrans in nursing women. No data shows that macrogol 4000 excreted through breast milk. The risk for infants is not excluded. Breastfeeding women are only used if the benefits are greater than the risk.

Medicinal interaction

The prescription doctor should be notified of any other drug being used by the patient simultaneously by oral. Because the stomach will be dehydrated when using Fortrans, oral medications may not be absorbed and should be used more than 2 hours before dehydration. Avoid oral medications before and after laxative taken until the examination is complete. For drugs with narrow treatment interval or with short -selling time, effectiveness can be specially affected.

Storage

Store at a temperature not exceeding 30ºC.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.